The patient was started on intravenous prednisolone, 60 mg/day. One day later she was afebrile; pustules were resolving. The diarrhea quickly resolved and she was discharged home. The foot lesion ...
Vilobelimab is a first-in-class anti-human complement factor C5a monoclonal antibody. The Food and Drug Administration (FDA) has granted Fast Track designation to vilobelimab for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback